1. Case report: 5-year progression free survival and complete liver response in a patient with metastatic breast cancer treated with everolimus plus exemestane. Issue 31 (31st July 2020) Authors: Krasniqi, Eriseld; Barchiesi, Giacomo; Mazzotta, Marco; Pizzuti, Laura; Villa, Alice; Barba, Maddalena; Vici, Patrizia Other Names: Saranathan. Maya section editor. Journal: Medicine Issue: Volume 99:Issue 31(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti‐HER2 agents in the real world setting. Issue 7 (7th August 2019) Authors: Pizzuti, Laura; Krasniqi, Eriseld; Barchiesi, Giacomo; Della Giulia, Marina; Izzo, Fiorentino; Sanguineti, Giuseppe; Marchetti, Paolo; Mazzotta, Marco; Giusti, Raffaele; Botticelli, Andrea; Gamucci, Teresa; Natoli, Clara; Grassadonia, Antonino; Tinari, Nicola; Iezzi, Laura; Tomao, Silverio; Tomao... Journal: International journal of cancer Issue: Volume 146:Issue 7(2020) Page Start: 1917 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real‐world evidence. Issue 11 (15th January 2020) Authors: Krasniqi, Eriseld; Pizzuti, Laura; Barchiesi, Giacomo; Sergi, Domenico; Carpano, Silvia; Botti, Claudio; Kayal, Ramy; Sanguineti, Giuseppe; Marchetti, Paolo; Botticelli, Andrea; Marinelli, Daniele; Gamucci, Teresa; Natoli, Clara; Grassadonia, Antonino; Tinari, Nicola; Tomao, Silverio; Tonini, Giu... Journal: Journal of cellular physiology Issue: Volume 235:Issue 11(2020:Nov.) Page Start: 7900 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗